SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems, Inc. due to alleged violations of federal securities laws related to misleading statements about the company's new Inspire V device and its market demand [2][5]. Group 1: Legal Investigation and Class Action - The firm is encouraging investors who suffered losses in Inspire Medical to contact them directly to discuss their legal options [1]. - There is a deadline of January 5, 2026, for investors to seek the role of lead plaintiff in a federal securities class action against Inspire Medical [2]. - The lead plaintiff is defined as the investor with the largest financial interest who directs the litigation on behalf of the class [8]. Group 2: Company Performance and Issues - Inspire Medical announced significant setbacks in the launch of its Inspire V device, citing delays due to incomplete training and onboarding at treatment centers [6]. - The company faced billing and reimbursement challenges, as necessary software updates for claims processing were not effective until July 1, 2025, leading to continued use of the older Inspire IV system [6]. - Inspire reported weak demand and excess inventory for the Inspire V, resulting in a more than 80% cut in its 2025 earnings guidance [7]. Group 3: Market Impact - Following the announcement of these issues, Inspire Medical's stock price dropped over 32% in one day, from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025, resulting in a loss of approximately $1.2 billion in market capitalization [7].